Chiral Technology: Market Research Report
This report analyzes the worldwide markets for Chiral Technology in US$ Million, both by Chiral Technology Enabling Products (Intermediates, Analytical, and Others) and by Chiral Technology End Use Markets (Pharmaceuticals, and Agrochemicals). The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. Also, a seven-year historic analysis is provided for these markets. The report profiles 38 companies including many key and niche players worldwide such as Albemarle Corporation, BASF AG, Cambrex Corp., Chiral Quest Inc., Dalco ChromTech AB, Daicel Chemical Industries Ltd., Chiral Technologies Worldwide, Chiral Technologies, Inc., Chiral Technologies Europe, DSM Pharmaceutical Products, Johnson Matthey PLC, Regis Technologies Inc., Shasun Chemicals and Drugs Limited, Solvias, Sigma Aldrich Corp, and Suven Life Sciences Ltd. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Contents
1.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Chiral Technology Enabling Products
Chiral Intermediates
Analytical Products
Other Products
Chiral Technology End-Use Markets
Pharmaceuticals
Agrochemicals
2.MARKET OVERVIEW
Bright Outlook for the Global Chiral Technology Market
Analysis by Product Segments and End use Markets
Table 1: World Chiral Technology Market by Product Segment (2009): Percentage Share Breakdown by Value Sales for Chiral Intermediates, Chiral Analytical Products, and Others (includes corresponding Graph/Chart)
Good Tidings for Chiral Technology
Market Drivers
Demand for Chiral-based Therapeutic Drugs Augments Growth
New Legislations Push Chiral Technology Demand
Key Market Trends
Organizations Extend Approaches
Companies’ Association with Universities
Trends in Chiral Processes
Increasing Reliance on Generic Approaches
Predominant Use of Polysaccharides Derivatives as CSPs
Automation: Introduction of Instruments Supporting Chiral Processes, a Growing Trend
3.CHIRAL TECHNOLOGY
An Insight into Chiral Technology
Techniques Used for Achieving Single-Isomers
Table 2: World Chiral Technology Market (2002 & 2010): Percentage Breakdown of Revenues by Techniques- Traditional Methods, Asymmetric Methods, and Biological Methods (includes corresponding Graph/Chart)
Importance and Advancements
4.CHIRAL TECHNOLOGY – AN OVERVIEW
Definitions
Chiral Technology Enabling Products
Chiral Intermediates
Analytical Products
Other Products
Chiral Technology End-Use Markets
Pharmaceuticals
Agrochemicals
Description
Functioning of Chiral Molecules
Chiral Preparation Process
Traditional Methods
Biological Methods
Asymmetric Methods
Chiral Separation
Factors Influencing the Efficacy of Chiral Separations
Recent Approaches in Chiral Separations
Extensive Use of Supercritical Fluid Chromatography (SFC)
Chromatography – The Widely Used Method for Separation
How it Works?
Chiral Mobile Phase Additive (CMPA)
Chiral Stationary Phase (CSP)
List of Newly Introduced Generic Versions of Derivatized Amylose and Cellulose Phases
Challenges and Novel Concepts in the Development of Chiral Stationary Phases
Novel Concepts
Chiral Recognition
Protein Chiral Stationary Phases
Carbohydrate Columns
Pirkle Columns
Crystallization
Solvent Extraction
Kinetic Resolution
Capillary Electrophoresis
Receptor Based Resolution
Miscellaneous Separative Techniques
Chiral Synthesis
5.CHIRAL TECHNOLOGY – DEVELOPMENT VS ACQUISITION
In-House Creation & Development
Acquisition of Technology
“Economics” of Chiral Technology
6.CHIRAL ANALYSIS
Chiral Analysis: A Primer
Chiral Analysis Products
Chiral Analytical Chromatography
Chiral Liquid Chromatography
Supercritical Fluid Chromatography - Substitute to LC for Enantiomer Separations
Chiral Gas Chromatography
Chiral Simulated Moving Bed Chromatography
Partition Chromatography
Adsorption Chromatography
Computer Assisted Resolution
Chiral Polarimetry
Other Chiral Analytical Techniques
Calorimetry
Differential Scanning Calorimetry (DSC)
Enzymatic Assay
Immunoassay
Isotope Dilution
Nuclear Magnetic Resonance (NMR)
X-Ray Crystallography
7.APPLICATION MARKETS
Pharmaceuticals – The Largest Market
Changing Face of the Pharmaceutical Industry: A Review
Analysis of Chiral Drugs
Select Companies Involved in Chiral Technology Market
Table 3: Single-Enantiomer Drugs Market Worldwide (2006- A Recent past Perspective): Sales of Select Leading Brands (In US$ Billion) (includes corresponding Graph/Chart)
Drugs Built on Chiral Technology
Analgesics
Anesthetics
Anti-Infective Products
Cardiovascular System (CVS) Products
Angiotensin-Converting Enzyme (ACE) Inhibitors
Beta-Blockers
Calcium Channel Blockers
Diuretics
Vasodilators
Central Nervous System (CNS) Agents
Anticonvulsants
Sedatives and Tranquilizers
Stimulants and Antidepressants
Oncogenic (Cancer-Treatment) Products
Biochemicals
Oligonucleotides
Oxyacids
Amino Acids
Sugars and Other Oligosaccharides
Vitamins
Peptides
Pesticides – A Thriving Market
Herbicides
Insecticides
Fungicides
Other Products
Liquid Crystals
Flavor and Aroma Chemicals
8.CHIRAL ISOMERISM
Organic Chemical Isomerism Types
Structural Isomerism
Chain Isomerism
Position Isomerism
Functional Group Isomerism
Stereoisomerism
Dynamic Isomerism (Tautomerism)
Patents
9.REGULATORY & ENVIRONMENTAL ISSUES- A REVIEW
10.PRODUCT INTRODUCTIONS/INNOVATIONS
Phenomenex Introduces Chiral Screening Service
AminoLogics Develops a Novel Chiral Converting Molecule for Amino Acids
Chiral Technologies Worldwide to Display 3-ìm and Protein-based Reversed Phase Columns
Chiral Technologies Introduces 3µm Chiral Stationary Phases for Rapid Analysis
Chiral Technologies Introduces 5µm Versions of Polysaccharide-Based Chiral Stationary
Semba Launches Semba Octave™ Chromatography System
Modular SFC to Launch Chiral Centrifugal Fraction Collector and Sample Concentration System
Chiral Technologies Introduces New Versions of Immobilized IC and IA Chiral Phases
PDR-Chiral Develops AutoMDS for Automated Screening of Chiral and Achiral Substances
Waters Introduces New Products Under the UPLC Line
11.PRODUCT INTRODUCTIONS/INNOVATIONS IN THE RECENT PAST- A PERSPECTIVE BUILDER
Sigma-Aldrich/Supelco Introduces Astec CHIROBIOTIC™ Chiral HPLC Columns
Sigma-Aldrich/Supelco Introduces Astec CYCLOBOND™ Chiral HPLC Columns
Chiral Technologies Introduces CHIRALPAK® IC Columns Under Polysaccharide Product Range
Degussa Develops Novel Processes to Synthesize (S) CAP
Regis Technologies, Inc. Launches RegisPack Chiral Columns
Sigma-Aldrich Introduces ChiroSolv™ Kits
Sigma-Aldrich Launches Ascentis Express HPLC Columns
Evolved Nanomaterial Releases Revolutionary Analytical Chiral Column
BASF Develops Novel Process to Produce Chiral Intermediates
Sepiatech Launches Sepmatix Parallel HPLC system
MACHEREY-NAGEL Launches Novel NUCLEOCEL CSP Columns
Eksigent to Launch Express™ HPLC System
Chiral Quest Launches C3 TunePhos
12.RECENT INDUSTRY ACTIVITY
WR Grace Takes Over Synthetech
Daicel Chiral to Start a New Branch in Beijing
Saltigo Concludes Process Development Agreement with Reuter Chemische
Chiral Technologies Europe Inks Global Licensing Agreement with University of Vienna
Shasun Announces Change of Name
CT Worldwide Announces the Launch of a Novel Microsite
Chiral Technologies Partners with Vanderbilt University’s Program in Drug Discovery
DSM Renews Co-Operation Agreement with Fudan University
Chiral Technologies Europe Inks Distribution Agreement with HICHROM
Dow Sells Dowpharma Small Molecules Business
Daicel Chemical Establishes New Subsidiary in China
Chiral Technologies Europe Takes Over ChromTech
Cambrex to Buy ProSyntest AS
13.CORPORATE ACTIVITY IN THE RECENT PAST- A PERSPECTIVE BUILDER
Johnson Matthey and X-Zyme Sign Licensing Agreement
Chiral Quest Starts a New Production Facility
Chiral Quest Completes Reverse Merger with Surg II
DSM and IEP Extend Partnership
Shasun Chemicals Acquires Rhodia Pharma Solutions
Sigma-Aldrich Corp Acquires Astec
Solvias Receives License for MeOBIPHEP Catalyst Technology
Codexis Acquires Juelich Fine Chemicals
ChiroBlock Exits from Chiral Compounds Business
Chiral Quest Opens New Facility in China
Chiral Quest to Supply C3 TunePhos to Phoenix Chemicals
Lonza and Codexis Sign Agreement for Biocatalysis Process
DSM Signs Licensing Agreement with Chiral Quest
Chiral Quest Signs Distribution Agreement with Aldrich Chemical
BASF and Solvias to Collaborate on Chiral Molecule Development
Chiral Quest and Avantium Enter into Partnership
14.FOCUS ON SELECT PLAYERS
Albemarle Corporation (USA)
BASF SE (Germany)
Cambrex Corp. (USA)
Chiral Quest Inc. (US)
Dalco ChromTech AB (Sweden)
Daicel Chemical Industries Ltd. (Japan)
Chiral Technologies Worldwide
Chiral Technologies, Inc. (USA)
Chiral Technologies Europe (France)
DSM Pharmaceutical Products (The Netherlands)
Johnson Matthey PLC (UK)
Regis Technologies, Inc. (USA)
Shasun Pharmaceuticals Limited (India)
Solvias (Switzerland)
Sigma Aldrich Corp. (USA)
Suven Life Sciences Ltd. (USA)
15.GLOBAL MARKET PERSPECTIVE
Table 4: World Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 5: World Historic Review for Chiral Technology Enabling Products by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 6: World 11-Year Perspective for Chiral Technology Enabling Products by Geographic Region – Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 7: World Recent Past, Current & Future Analysis for Chiral Intermediates by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 8: World Historic Review for Chiral Intermediates by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 9: World 11-Year Perspective for Chiral Intermediates by Geographic Region – Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 10: World Recent Past, Current & Future Analysis for Chiral Analytical Products by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 11: World Historic Review for Chiral Analytical Products by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 12: World 11-Year Perspective for Chiral Analytical Products by Geographic Region – Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 13: World Recent Past, Current & Future Analysis for Other Chiral Technology Enabling Products by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 14: World Historic Review for Other Chiral Technology Enabling Products by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 15: World 11-Year Perspective for Other Chiral Technology Enabling Products by Geographic Region – Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 16: World Recent Past, Current & Future Analysis for Chiral Technology in Pharmaceuticals by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 17: World Historic Review for Chiral Technology in Pharmaceuticals by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 18: World 11-Year Perspective for Chiral Technology in Pharmaceuticals by Geographic Region – Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 19: World Recent Past, Current & Future Analysis for Chiral Technology in Agrochemicals by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 20: World Historic Review for Chiral Technology in Agrochemicals by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 21: World 11-Year Perspective for Chiral Technology in Agrochemicals by Geographic Region – Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
16.THE UNITED STATES
A. Market Analysis
Overview
B. Market Analytics
Table 22: US Recent Past, Current and Future Analysis for Chiral Technology Enabling Products by Product Segment – Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 23: US Historic Review for Chiral Technology Enabling Products by Product Segment – Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 24: US 11-Year Perspective for Chiral Technology Enabling Products by Product Segment – Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 25: US Recent Past, Current & Future Analysis for Chiral Technology by End-Use Segment – Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 26: US Historic Review for Chiral Technology by End-Use Segment – Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 27: US 11-Year Perspective for Chiral Technology by End-Use Segment – Percentage Breakdown of Value Sales for Pharmaceuticals, and Agrochemicals Markets for Years 2005, 2010 & 2015
17.JAPAN
A. Market Analysis
Outlook
B. Market Analytics
Table 28: Japanese Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Product Segment – Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 29: Japanese Historic Review for Chiral Technology Enabling Products by Product Segment – Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 30: Japanese 11-Year Perspective for Chiral Technology Enabling Products by Product Segment – Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2005, 2005 & 2015 (includes corresponding Graph/Chart)
Table 31: Japanese Recent Past, Current & Future Analysis for Chiral Technology by End-Use Segment – Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 32: Japanese Historic Review for Chiral Technology by End-Use Segment – Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 33: Japanese 11-Year Perspective for Chiral Technology by End-Use Segment – Percentage Breakdown of Value Sales for Pharmaceuticals and Agrochemicals Markets for Years 2005, 2005 & 2015
18.EUROPE
A. Market Analysis
Overview
B. Market Analytics
Table 34: European Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Product Segment – Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 35: European Historic Review for Chiral Technology Enabling Products by Product Segment – Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 36: European 11-Year Perspective for Chiral Technology Enabling Products by Product Segment – Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 37: European Recent Past, Current and Future Analysis for Chiral Technology by End-Use Segment – Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 38: European Historic Review for Chiral Technology by End-Use Segment – Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 39: European 11-Year Perspective for Chiral Technology by End-Use Segment – Percentage Breakdown of Value Sales for Pharmaceuticals, and Agrochemicals Markets for Years 2005, 2010 & 2015
19.REST OF WORLD
A. Market Analysis
Outlook
India
Chiral Drugs in the Indian Market
China-A Hub for Pharmaceutical Manufacturing
B. Market Analytics
Table 40: Rest of World Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Product Segment – Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 41: Rest of World Historic Review for Chiral Technology Enabling Products by Product Segment – Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 42: Rest of World 11-Year Perspective for Chiral Technology Enabling Products by Product Segment – Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
Table 43: Rest of World Recent Past, Current & Future Analysis for Chiral Technology by End-Use Segment – Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 44: Rest of World Historic Review for Chiral Technology by End-Use Segment – Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
Table 45: Rest of World 11-Year Perspective for Chiral Technology by End-Use Segment – Percentage Breakdown of Value Sales for Pharmaceuticals, and Agrochemicals Markets for Years 2005, 2010 & 2015
COMPETITIVE LANDSCAPE
Total Companies Profiled: 38 (including Divisions/Subsidiaries - 48)
Region/CountryPlayers
The United States29
Canada
Japan
Europe
France
Germany
The United Kingdom
Italy
Rest of Europe
Asia-Pacific (Excluding Japan) Skip to top